Better Therapeutics, Inc.
BTTX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15,740 | $40,566 | $123 | $757 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,706 | $4,685 | $340 | $230 |
| Total Curr. Assets | $18,446 | $45,251 | $463 | $987 |
| Property Plant & Equip (Net) | $121 | $82 | $89 | $183 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3,888 | $5,077 | $5,555 | $3,267 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $488 | $548 | $280 | $444 |
| Total NC Assets | $4,497 | $5,707 | $5,924 | $3,894 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22,943 | $50,958 | $6,387 | $4,881 |
| Liabilities | – | – | – | – |
| Payables | $3,035 | $1,523 | $514 | $335 |
| Short-Term Debt | $4,532 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5,927 | $3,210 | $99 | $151 |
| Total Curr. Liab. | $13,494 | $4,733 | $613 | $486 |
| LT Debt | $10,348 | $9,505 | $640 | $5,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $152 | $0 |
| Other NC Liab. | $0 | $0 | $11,740 | $0 |
| Total NC Liab. | $10,348 | $9,505 | $12,532 | $5,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $23,842 | $14,238 | $13,145 | $5,486 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $24,204 |
| Common Stock | $2 | $2 | $1 | $212 |
| Retained Earnings | -$111,503 | -$71,743 | -$31,408 | -$25,021 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $110,602 | $108,461 | $445 | $0 |
| Total Equity | -$899 | $36,720 | -$6,758 | -$605 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $22,943 | $50,958 | $6,387 | $4,881 |
| Net Debt | -$860 | -$31,061 | $517 | $4,243 |